{"filing":{"accession_number":"0001492298-26-000027","cik":"0001492298","ticker":"SBRA","company_name":"Sabra Health Care REIT, Inc.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"sbra-20260803.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1492298/000149229826000027/sbra-20260803.htm"},"events":[{"id":23407,"run_id":21160,"accession_number":"0001492298-26-000027","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Sabra Health Care REIT reported second quarter 2026 financial results on August 3, 2026, disclosing a net loss of $(0.10) per diluted share, FFO of $(0.02), Normalized FFO of $0.38, and AFFO of $0.39, along with consolidated financial statements and operational metrics including EBITDARM coverage ratios and investment activity.","company_name":"Sabra Health Care REIT, Inc.","ticker":"SBRA","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":[{"id":23623,"accession_number":"0001492298-26-000027","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Item 2.02 discloses Sabra's second quarter 2026 financial results via press release dated August 3, 2026. The filing includes consolidated statements of loss/income, balance sheet data, and per-share metrics (net loss of $(0.10), FFO of $(0.02), Normalized FFO of $0.38, AFFO of $0.39). This is a standard quarterly earnings release with detailed financial statements and operational metrics, making it a clear earnings_release event that would materially affect investor assessment of the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:19.956569+00:00","company_name":"","ticker":null,"filing_date":""},{"id":23624,"accession_number":"0001492298-26-000027","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 furnishes a press release (Exhibit 99.1) disclosing Sabra's Q2 2026 financial results, including net loss of $(0.10) per diluted share, FFO and AFFO metrics, EBITDARM coverage ratios, and investment activity. The release explicitly states \"SABRA REPORTS SECOND QUARTER 2026 RESULTS\" and includes consolidated statements of income and balance sheet data. This is a standard quarterly earnings release material to investors assessing the REIT's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:19.956569+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23623,"accession_number":"0001492298-26-000027","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Item 2.02 discloses Sabra's second quarter 2026 financial results via press release dated August 3, 2026. The filing includes consolidated statements of loss/income, balance sheet data, and per-share metrics (net loss of $(0.10), FFO of $(0.02), Normalized FFO of $0.38, AFFO of $0.39). This is a standard quarterly earnings release with detailed financial statements and operational metrics, making it a clear earnings_release event that would materially affect investor assessment of the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:19.956569+00:00","company_name":"Sabra Health Care REIT, Inc.","ticker":"SBRA","filing_date":"2026-08-03"},{"id":23624,"accession_number":"0001492298-26-000027","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 furnishes a press release (Exhibit 99.1) disclosing Sabra's Q2 2026 financial results, including net loss of $(0.10) per diluted share, FFO and AFFO metrics, EBITDARM coverage ratios, and investment activity. The release explicitly states \"SABRA REPORTS SECOND QUARTER 2026 RESULTS\" and includes consolidated statements of income and balance sheet data. This is a standard quarterly earnings release material to investors assessing the REIT's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:19.956569+00:00","company_name":"Sabra Health Care REIT, Inc.","ticker":"SBRA","filing_date":"2026-08-03"}]}